• Shopping Cart
    There are no items in your cart

ASTM F 3369 : 2019 : EDT 1

Current

Current

The latest, up-to-date edition.

Standard Guide for Assessing the Skeletal Myoblast Phenotype

Available format(s)

Hardcopy , PDF

Language(s)

English

Published date

08-05-2019

€56.53
Excluding VAT

Myogenic differentiation is a process regulated by specific transcription factors and signaling molecules that have been shown to induce a myogenic phenotype.

Committee
F 04
DocumentType
Guide
Pages
8
PublisherName
American Society for Testing and Materials
Status
Current
Supersedes

1.1Myogenic differentiation is a process regulated by specific transcription factors and signaling molecules that have been shown to induce a myogenic phenotype. Transcription factors mark the stages of myogenesis and act as benchmarks for use in myogenic assays.

1.2This guide applies to mammalian cells but does not apply to non-mammalian cells as the myogenic markers for non-mammalian cells can be different than those described here.

1.3This guide proposes appropriate markers to measure when conducting myogenic differentiation assays. This guide describes the stages for multipotent stem cell differentiation toward myoblasts and myotubes. This guide provides information about the appropriate methods to determine myogenic differentiation. This guide does not provide information about media, supplements, or substrates that drive differentiation toward a myogenic phenotype.

1.4The purpose of this guide is to act as an aid for work performed in the area of skeletal myogenesis. Using this guide, researchers should be able to understand which skeletal muscle markers are best suited for experiments. This guide will improve consistency for studies of myogenic differentiation of multipotent stem cells by identifying appropriate markers for each stage leading to myocyte differentiation. It should be noted that myoblast differentiation in vitro may not be predictive of results that may be obtained in vivo.

1.5This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.

1.6This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.

ASTM F 3510 : 2021 Standard Guide for Characterizing Fiber-Based Constructs for Tissue-Engineered Medical Products

ASTM F 2312 : 2024 Standard Terminology Relating to Tissue Engineered Medical Products
ASTM F 2312 : 2011 Standard Terminology Relating to Tissue Engineered Medical Products
ASTM F 2312 : 2011 : R2020 Standard Terminology Relating to Tissue Engineered Medical Products
ASTM F 2312 : 2003 Standard Terminology Relating to Tissue Engineered Medical Products

Access your standards online with a subscription

Features

  • Simple online access to standards, technical information and regulations.

  • Critical updates of standards and customisable alerts and notifications.

  • Multi-user online standards collection: secure, flexible and cost effective.